The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia

Külp M, Siemund AL, Larghero P, Dietz A, Alten J, Cario G, Eckert C, Caye-
Eude A, Cavé H, Bardini M, Cazzaniga G, De Lorenzo P, Valsecchi MG, Diehl L,
Bonig H, Meyer C, Marschalek R.

Recurrent Germline Variant in RAD21 Predisposes Children to Lymphoblastic Leukemia or Lymphoma

Schedel A, Friedrich UA, Morcos MNF, Wagener R, Mehtonen J, Watrin T, Saitta
C, Brozou T, Michler P, Walter C, Försti A, Baksi A, Menzel M, Horak P,
Paramasivam N, Fazio G, Autry RJ, Fröhling S, Suttorp M, Gertzen C, Gohlke H,
Bhatia S, Wadt K, Schmiegelow K, Dugas M, Richter D, Glimm H, Heinäniemi M,
Jessberger R, Cazzaniga G, Borkhardt A, Hauer J, Auer F.

Genetic and Epigenetic Characterization of a Discordant KMT2A/AFF1-Rearranged Infant Monozygotic Twin Pair

Russo A, Viberti C, Mareschi K, Casalone E, Guarrera S, Birolo G, Cazzaniga
G, Corral L, Trentin L, Basso G, Fagioli F, Matullo G.

Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders

Stewart JP, Gazdova J, Darzentas N, Wren D, Proszek P, Fazio G, Songia S,
Alcoceba M, Sarasquete ME, Villarese P, van der Klift MY, Heezen KC, McCafferty
N, Pal K, Catherwood M, Kim CS, Srivastava S, Kroeze LI, Hodges E, Stamatopoulos
K, Klapper W, Genuardi E, Ferrero S, van den Brand M, Cazzaniga G, Davi F,
Sutton LA, Garcia-Sanz R, Groenen PJTA, Macintyre EA, Brüggemann M, Pott C,
Langerak AW, Gonzalez D; EuroClonality-NGS Working Group.

Utilizing the prognostic impact of minimal residual disease in treatment decisions for pediatric acute lymphoblastic leukemia

Ceppi F, Rizzati F, Colombini A, Conter V, Cazzaniga G.

Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

Boer JM, Valsecchi MG, Hormann FM, Antić Ž, Zaliova M, Schwab C, Cazzaniga
G, Arfeuille C, Cavé H, Attarbaschi A, Strehl S, Escherich G, Imamura T, Ohki K,
Grüber TA, Sutton R, Pastorczak A, Lammens T, Lambert F, Li CK, Carrillo de
Santa Pau E, Hoffmann S, Möricke A, Harrison CJ, Den Boer ML, De Lorenzo P, Stam
RW, Bergmann AK, Pieters R.

Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium

Buchmann S, Schrappe M, Baruchel A, Biondi A, Borowitz M, Campbell M, Cario
G, Cazzaniga G, Escherich G, Harrison CJ, Heyman M, Hunger SP, Kiss C, Liu HC,
Locatelli F, Loh ML, Manabe A, Mann G, Pieters R, Pui CH, Rives S, Schmiegelow
K, Silverman LB, Stary J, Vora A, Brown P.

Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts

Quintarelli C, Guercio M, Manni S, Boffa I, Sinibaldi M, Di Cecca S, Caruso
S, Abbaszadeh Z, Camera A, Cembrola B, Ciccone R, Orfao A, Martin-Martin L,
Gutierrez-Herrero S, Herrero-Garcia M, Cazzaniga G, Nunes V, Songia S, Marcatili
P, Marin FI, Ruella M, Bertaina V, Vinti L, Del Bufalo F, Algeri M, Merli P, De
Angelis B, Locatelli F.

Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLL-rearranged B cell acute lymphoblastic leukemia

Tejedor JR, Bueno C, Vinyoles M, Petazzi P, Agraz-Doblas A, Cobo I, Torres-
Ruiz R, Bayón GF, Pérez RF, López-Tamargo S, Gutierrez-Agüera F, Santamarina-
Ojeda P, Ramírez-Orellana M, Bardini M, Cazzaniga G, Ballerini P, Schneider P,
Stam RW, Varela I, Fraga MF, Fernández AF, Menéndez P.

Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis

Saettini F, Fazio G, Moratto D, Galbiati M, Zucchini N, Ippolito D, Dinelli
ME, Imberti L, Mauri M, Melzi ML, Bonanomi S, Gerussi A, Pinelli M, Barisani C,
Bugarin C, Chiarini M, Giacomelli M, Piazza R, Cazzaniga G, Invernizzi P,
Giliani SC, Badolato R, Biondi A.